Cara Therapeutic Stock Technical Analysis
| CARA Stock | USD 0.79 0.01 1.28% |
As of the 6th of May, Cara Therapeutic shows the Mean Deviation of 5.46, downside deviation of 6.15, and Risk Adjusted Performance of 0.0728. Cara Therapeutic technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for Cara Therapeutic, which can be compared to its peers. Please confirm Cara Therapeutic jensen alpha and the relationship between the value at risk and kurtosis to decide if Cara Therapeutic is priced correctly, providing market reflects its regular price of 0.79 per share. As Cara Therapeutic is a penny stock we also strongly suggest to validate its total risk alpha numbers.
Cara Therapeutic Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Cara, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CaraCara |
Cara Therapeutic Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 14.29 | Strong Buy | 6 | Odds |
Most Cara analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Cara stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Cara Therapeutic, talking to its executives and customers, or listening to Cara conference calls.
Cara Therapeutic technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Cara Therapeutic Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Cara Therapeutic volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Cara Therapeutic Trend Analysis
Use this graph to draw trend lines for Cara Therapeutic. You can use it to identify possible trend reversals for Cara Therapeutic as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Cara Therapeutic price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Cara Therapeutic Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Cara Therapeutic applied against its price change over selected period. The best fit line has a slop of 0.0002 , which means Cara Therapeutic will continue generating value for investors. It has 122 observation points and a regression sum of squares at 0.0, which is the sum of squared deviations for the predicted Cara Therapeutic price change compared to its average price change.About Cara Therapeutic Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Cara Therapeutic on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Cara Therapeutic based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Cara Therapeutic price pattern first instead of the macroeconomic environment surrounding Cara Therapeutic. By analyzing Cara Therapeutic's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Cara Therapeutic's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Cara Therapeutic specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 18.26 | 38.82 | 69.93 | 66.43 | PTB Ratio | 2.72 | 3.63 | 0.7 | 0.67 |
Cara Therapeutic May 6, 2024 Technical Indicators
Most technical analysis of Cara help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Cara from various momentum indicators to cycle indicators. When you analyze Cara charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0728 | |||
| Market Risk Adjusted Performance | 0.1448 | |||
| Mean Deviation | 5.46 | |||
| Semi Deviation | 5.53 | |||
| Downside Deviation | 6.15 | |||
| Coefficient Of Variation | 990.77 | |||
| Standard Deviation | 7.11 | |||
| Variance | 50.57 | |||
| Information Ratio | 0.0898 | |||
| Jensen Alpha | 0.3431 | |||
| Total Risk Alpha | (0.07) | |||
| Sortino Ratio | 0.1038 | |||
| Treynor Ratio | 0.1348 | |||
| Maximum Drawdown | 29.73 | |||
| Value At Risk | (9.00) | |||
| Potential Upside | 13.75 | |||
| Downside Variance | 37.78 | |||
| Semi Variance | 30.56 | |||
| Expected Short fall | (6.73) | |||
| Skewness | 0.6516 | |||
| Kurtosis | 0.2432 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cara Therapeutic. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Cara Stock refer to our How to Trade Cara Stock guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Complementary Tools for Cara Stock analysis
When running Cara Therapeutic's price analysis, check to measure Cara Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cara Therapeutic is operating at the current time. Most of Cara Therapeutic's value examination focuses on studying past and present price action to predict the probability of Cara Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cara Therapeutic's price. Additionally, you may evaluate how the addition of Cara Therapeutic to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
Is Cara Therapeutic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cara Therapeutic. If investors know Cara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cara Therapeutic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.19) | Revenue Per Share 0.387 | Quarterly Revenue Growth (0.08) | Return On Assets (0.49) | Return On Equity (1.10) |
The market value of Cara Therapeutic is measured differently than its book value, which is the value of Cara that is recorded on the company's balance sheet. Investors also form their own opinion of Cara Therapeutic's value that differs from its market value or its book value, called intrinsic value, which is Cara Therapeutic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cara Therapeutic's market value can be influenced by many factors that don't directly affect Cara Therapeutic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cara Therapeutic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cara Therapeutic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cara Therapeutic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.